Four questions with Shivaani Kummar, MD, FACP
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Dr. Kummar’s work is dedicated to early phase clinical trials — discovering new therapies for cancer and giving more people access to safe, experimental cancer treatments.
Dr. Pennesi led the first-ever CRISPR gene-editing procedure within the human body, which is showing promising results. We asked him four questions about his research and what this breakthrough could mean.
Penelope was born with a rare blood disorder. When complication after complication hit, her family turned to OHSU Doernbecher Children’s Hospital, who helped her family through a complex diagnosis.
Jill Eiland was recently named interim president to lead the OHSU Foundation. Get to know Jill, in her own words, and what she’s looking forward to as she leads the Foundation through this transition.
Andrew was diagnosed with a brain tumor at 4. With care from OHSU Doernbecher Children’s Hospital, Andrew is now a thriving fourth-grader who loves playing video games.
Mason arrived 13 weeks early. At just two pounds, he was taken to OHSU Doernbecher’s NICU — and the specialized care he received made all the difference.